Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value

PharmacoEconomics - Open(2020)10.1007/s41669-020-00243-6Source: DataRank Database

Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value is a research paper published in PharmacoEconomics - Open (2020). On theSindex it has a DataRank of 0.524. It has been cited 32 times.

N/A

0.524DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.68)OA: goldTopics (20)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.524

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (3)

Peter B. Bach ORCID,Matthew R. Baldwin ORCID,Michaela R. Anderson ORCID

Live enrichment

PubMed:33315210 OpenAlex:https://openalex.org/W3113095254

National Heart, Lung, and Blood Institute

Grant: K23 HL 150280

National Institutes of Health

Grant: UL1 TR001873

National Institutes of Health

Grant: 3UL1TR001873-07S1

Clinical and Translational Science Award

NCI NIH HHS

Grant: P30 CA008748

NHLBI NIH HHS

Grant: L30 HL143645

FWCI

0.68

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2025

goldLicense: cc-by-nc

journalhttps://link.springer.com/content/pdf/10.1007/s41669-020-00243-6.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s41669-020-00243-6.pdf

publisherhttp://link.springer.com/content/pdf/10.1007/s41669-020-00243-6.pdf

publisherhttp://link.springer.com/article/10.1007/s41669-020-00243-6/fulltext.html

journalhttps://doi.org/10.1007/s41669-020-00243-6

Fields of Study

COVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentCOVID-19 and healthcare impacts03 medical and health sciences0302 clinical medicine

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakValue (mathematics)MedicineBetacoronavirusVirologyInternal medicineStatisticsMathematicsOutbreakPharmacologyHealth PolicyResearch LetterPharmacology (medical)

Sustainable Development Goals

SDG 3: 3. Good health